← Ecosystem map
M
MOMM Diagnostics
Develops rapid near-patient testing for preeclampsia using its eFlow platform.
At a glance
- What it offers
- Diagnostics / Diagnostic Test
- Primary health focus
- Pregnancy
- Who it supports
- Patients and Consumers, Healthcare Professionals
- Company stage
- Early Commercial
About
Need addressed
Pregnancy & maternal health
Organisation’s contribution
Strong Swiss maternal-health diagnostics company with Empa/FHNW/CSEM links.
Women’s health focus
Women’s Health Core
Primary health area
PregnancyProduct & development
- Funding disclosed
- CHF 1.2 million raised, as reported by Venturelab on 31 May 2022.